The largest holder of Xylem stock is BlackRock Advisors LLC, with 15.8 million shares (6.75% of the company), worth about $1.74 billion as of September 25, 2026. The 10 largest holders together own 39.0%.
In Q2 2026, 1,135 institutional holdings reports listed shares worth $26.10 billion.
Insiders reported 55 transactions in the last two years: 9 sales worth $5.49 million and 2 purchases. The newest one on file is from May 14, 2026 (Tretikov Lila, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 14, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 15.8 million | 6.75% | $1.7B |
| Vanguard Capital Management LLC | 15.5 million | 6.65% | $1.7B |
| Vanguard Portfolio Management LLC | 12.6 million | 5.41% | $1.4B |
| State Street Corporation | 11.4 million | 4.90% | $1.3B |
| BlackRock Life Ltd. | 8.9 million | 3.80% | $977.0M |
| Geode Capital Management LLC | 6.3 million | 2.72% | $699.0M |
| Cramer Rosenthal McGlynn LLC | 5.5 million | 2.35% | $604.0M |
| CPR Asset Management SA | 5.1 million | 2.19% | $562.0M |
| Invesco Advisers, Inc. | 5.1 million | 2.19% | $562.0M |
| BNY Mellon Investment Adviser, Inc. | 4.7 million | 2.00% | $514.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,135 | – | $26.1B |
| Q1 2026 | 1,147 | 218.0 million | $26.0B |
| Q4 2025 | 1,161 | – | $30.7B |
| Q3 2025 | 1,124 | – | $32.3B |
| Q2 2025 | 1,109 | 225.0 million | $29.1B |
| Q1 2025 | 1,077 | 227.0 million | $27.0B |
| Q4 2024 | 1,047 | 225.0 million | $26.4B |
| Q3 2024 | 1,066 | 220.0 million | $29.9B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Tretikov Lila | May 14, 2026 | Director | Stock Award(Grant) at price 116.88 per share. | $199,982 |
| Ellis Earl Ray | May 14, 2026 | Director | Stock Award(Grant) at price 116.88 per share. | $199,982 |
| Mcshane Geri-Michelle | May 7, 2026 | Officer | Sale at price 117.46 per share. | $501,437 |
| Mcshane Geri-Michelle | May 7, 2026 | Officer | Conversion of Exercise of derivative security at price 86.76 per share. | $273,034 |
| Peribere Jerome A | May 4, 2026 | Director | Purchase at price 116.61 per share. | $141,098 |
| Yarkadas Hayati | Mar 2, 2026 | Officer | Stock Award(Grant) at price 0.00 - 128.98 per share. | $1.6M |
| Cozad Stacy Lancaster | Mar 2, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Grogan William K. | Mar 2, 2026 | Chief Financial Officer | Stock Award(Grant) at price 0.00 - 128.98 per share. | $1.7M |
| Aulick Rodney O | Mar 2, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Mcgann Michael J | Mar 2, 2026 | Officer | Stock Award(Grant) at price 0.00 - 128.98 per share. | $668,116 |
| Cho Albert | Mar 2, 2026 | Officer | Stock Award(Grant) at price 0.00 - 128.98 per share. | $479,161 |
| Emmerich Meredith | Mar 2, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 55 insider transactions in the last two years.
BlackRock Advisors LLC, with 6.75% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.65%) and Vanguard Portfolio Management LLC (5.41%).
1,135 institutional holdings reports listed Xylem shares in Q2 2026 worth $26.10 billion.
In the last two years insiders reported 9 sales and 2 purchases (55 transactions in all); the newest on file is from May 14, 2026.